Moderna's Early COVID-19 Vaccine Trials Show Promising Results

<p>There was some good news in the fight against coronavirus on Monday as drug maker Moderna said that its vaccine induced immune responses in healthy volunteers in a clinical study. The volunteers made antibodies that matched or exceeded the levels found in patients who had recovered after contracting the virus. Moderna will now move into Phase 2 trials with more people involved in that study and then Phase 3 they hope to begin in July. Moderna ultimately hopes to have something ready by the fall, but we are still some time away from having a vaccine to be distributed widely. I'll tell you what you need to know.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>